Portfolio (Quarterly)
Guide ↗
FARALLON CAPITAL MANAGEMENT LLC
· CIK 0000909661| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 41 | BIDU | BAIDU INC | Communication Services | 443,785.0 | $49.4M | 0.28% | NEW | — | $111.42 | +21.5% |
| 42 | CGON | CG ONCOLOGY INC | Healthcare | 674,000.0 | $45.6M | 0.26% | NEW | — | $67.68 | -1.1% |
| 43 | AZN | ASTRAZENECA PLC | Healthcare | 226,499.0 | $44.7M | 0.26% | NEW | — | $197.22 | -7.9% |
| 44 | — | VNET GROUP INC | — | 45,000,000.0 | $44.5M | 0.25% | NEW | — | $0.99 | — |
| 45 | MRK | MERCK & CO INC | Healthcare | 361,000.0 | $43.4M | 0.25% | NEW | — | $120.29 | -5.7% |
| 46 | ACHC | ACADIA HEALTHCARE COMPANY IN | Healthcare | 1,736,800.0 | $40.6M | 0.23% | NEW | — | $23.39 | +10.3% |
| 47 | WELL | WELLTOWER INC | Real Estate | 200,000.0 | $39.5M | 0.23% | NEW | — | $197.71 | +10.1% |
| 48 | IMVT | IMMUNOVANT INC | Healthcare | 1,546,000.0 | $38.4M | 0.22% | NEW | — | $24.84 | +16.6% |
| 49 | ENTA | ENANTA PHARMACEUTICALS INC | Healthcare | 2,871,862.0 | $36.3M | 0.21% | NEW | — | $12.63 | +9.3% |
| 50 | JNJ | JOHNSON & JOHNSON | Healthcare | 148,000.0 | $36.2M | 0.21% | NEW | — | $244.44 | -5.6% |
| 51 | BBNX | BETA BIONICS INC | Healthcare | 3,607,920.0 | $36.2M | 0.21% | NEW | — | $10.02 | -5.6% |
| 52 | — | ASSEMBLY BIOSCIENCES INC | — | 1,227,590.0 | $34.1M | 0.19% | NEW | — | $27.75 | — |
| 53 | JOYY | JOYY INC | Communication Services | 578,200.0 | $33.8M | 0.19% | NEW | — | $58.39 | -1.8% |
| 54 | — | STRATEGY INC | — | 39,500,000.0 | $32.9M | 0.19% | NEW | — | $0.83 | — |
| 55 | NTES | NETEASE COM INC | Technology | 291,219.0 | $32.6M | 0.19% | NEW | — | $111.94 | +3.9% |
| 56 | NVO | NOVO-NORDISK A S | Healthcare | 782,000.0 | $28.7M | 0.16% | NEW | — | $36.75 | +24.6% |
| 57 | BITW | BITWISE 10 CRYPTO INDEX ETF | Financial Services | 603,000.0 | $26.9M | 0.15% | NEW | — | $44.61 | +14.0% |
| 58 | — | PERCEPTIVE CAP SOLUTIONS COR | — | 2,250,000.0 | $24.7M | 0.14% | NEW | — | $10.97 | — |
| 59 | RPRX | ROYALTY PHARMA PLC | Healthcare | 493,000.0 | $23.6M | 0.14% | NEW | — | $47.97 | +11.3% |
| 60 | NERV | MINERVA NEUROSCIENCES INC | Healthcare | 2,365,000.0 | $14.2M | 0.08% | NEW | — | $6.03 | -13.5% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
58.1%
Financial Services
14.1%
Technology
13.2%
Consumer Cyclical
5.9%
Industrials
4.5%
Communication Services
4.0%
Real Estate
0.3%
Energy
0.0%
Consumer Defensive
0.0%
Basic Materials
0.0%